This inventor holds 1 USPTO granted patent. Top assignee: National Dong Hwa University. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Innovations of Jui-Hsin Su in Cancer Treatment
Introduction
Jui-Hsin Su is a notable inventor based in Hualien, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for cancer treatment. His work focuses on scalarane sesterterpenoids, which have shown potential as effective anticancer agents.
Latest Patents
Jui-Hsin Su holds a patent for a pharmaceutical composition that includes scalarane sesterterpenoids and meroditerpenoids. This patent, titled "Scalarane sesterterpenoid, pharmaceutical composition and topoisomerase II and Hsp90 inhibitor for treating cancer, and use and preparation method thereof," discloses compounds that can act as inhibitors targeting topoisomerase II and Hsp90. The compounds are extracted from specific sponge species and have demonstrated promising anticancer properties.
Career Highlights
Jui-Hsin Su is affiliated with National Dong Hwa University, where he continues to engage in research and development in the field of pharmaceuticals. His innovative approach to cancer treatment has garnered attention in the scientific community.
Collaborations
Jui-Hsin Su has collaborated with several colleagues, including Mei-Chin Lu and Ping-Jyun Sung, who contribute to his research efforts. Their combined expertise enhances the potential for groundbreaking discoveries in cancer treatment.
Conclusion
Jui-Hsin Su's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. His contributions through patents and collaborations highlight the importance of research in developing effective treatments.